Newmont Corporation (NEM) Stock Outlook: Analyst Upgrades, Gold Supercycle and 2026 Forecasts as of December 7, 2025

Newmont Corporation (NEM) Stock Outlook: Analyst Upgrades, Gold Supercycle and 2026 Forecasts as of December 7, 2025

Newmont Corporation (NYSE: NEM), the world’s largest gold producer, heads into year‑end 2025 riding one of the strongest rallies in its modern history. The stock now trades just under $90 a share, after gaining roughly 135–145% year to date, dramatically outperforming both the broader market and most peers.Trefis+1 Behind that surge is a rare combination of record gold prices near $4,300 per ounce, aggressive cost-cutting after the Newcrest acquisition, and a step-change in free cash flow that has turned Newmont into one of the key ways to play the current “gold supercycle.”Newmont Corporation+3Barron’s+3Reuters+3 At the same time, the rally has
7 December 2025
Honeywell International Inc (HON) Stock Today: Latest News, 2026 Outlook and Analyst Forecasts – December 7, 2025

Honeywell International Inc (HON) Stock Today: Latest News, 2026 Outlook and Analyst Forecasts – December 7, 2025

Honeywell International Inc. (NASDAQ: HON) heads into the final weeks of 2025 in the middle of a once‑in‑a‑generation breakup, a major energy technology win, and a tug‑of‑war between booming aerospace demand and a weak industrial automation business. As of the latest close, Honeywell stock finished at $191.33 per share, giving the company a market capitalization of roughly $121–122 billion. That’s about 12% lower than its 2024 year‑end valuation, reflecting a tough year for the stock despite generally solid earnings. Public Below is a detailed look at today’s (December 7, 2025) most important HON stock news, fresh forecasts, and what they
7 December 2025
Bengaluru’s Namma Metro in 2025: Yellow Line Boost, Pink Line Delay and Blue Line Push as Network Targets 175 km by 2027

Bengaluru’s Namma Metro in 2025: Yellow Line Boost, Pink Line Delay and Blue Line Push as Network Targets 175 km by 2027

Bengaluru, December 7, 2025 — Namma Metro is in the middle of its most transformative phase yet. The long-awaited Yellow Line to Electronic City is finally running, ridership has crossed the one‑million‑a‑day mark, the Pink Line is inching towards a 2026 opening, and the state government has set up a special monitoring group to keep the airport‑bound Blue Line on track. At the same time, Bangalore Metro Rail Corporation Limited (BMRCL) managing director J Ravishankar has publicly committed to expanding the city’s metro network from about 96 km today to 175 km by 2027 and 225 km by 2030, with
7 December 2025
Lam Research (LRCX) Stock Outlook: AI Chip Boom, Analyst Targets and 2026 Forecasts as of December 7, 2025

Lam Research (LRCX) Stock Outlook: AI Chip Boom, Analyst Targets and 2026 Forecasts as of December 7, 2025

Lam Research Corp. (NASDAQ: LRCX) sits at the heart of the AI and memory semiconductor build‑out, and Wall Street is watching it closely. After a strong fiscal Q1 2026, fresh guidance and a series of bullish research notes, the stock is now trading just below its recent highs while analysts debate whether the AI payoff is fully priced in. Lam Research stock today: price, valuation and market context As of the latest close, Lam Research shares trade around $158.70, up just over 1% in Friday’s session and still roughly 5% below their 52‑week high near $167.MarketWatch+1 At that level, Lam
American Express (AXP) Stock on 7 December 2025: Latest News, Analyst Forecasts and 2026 Outlook

American Express (AXP) Stock on 7 December 2025: Latest News, Analyst Forecasts and 2026 Outlook

American Express Company (NYSE: AXP) heads into year‑end 2025 trading just below record highs, powered by resilient spending from affluent cardmembers and a strong third quarter – but with Wall Street increasingly split on whether the stock is now fully priced. As of the latest close, AXP is changing hands around $370 per share, near a 12‑month high a little above $377 and implying a market value of roughly $255 billion.MarketBeat Below is a deep dive into the most recent news, earnings, forecasts and institutional moves around American Express as of 7 December 2025. Key Takeaways American Express Stock Price
7 December 2025
FuelCell Energy (FCEL) Stock on December 7, 2025: Rally, Hydrogen Pivot and Q4 Earnings Countdown

FuelCell Energy (FCEL) Stock on December 7, 2025: Rally, Hydrogen Pivot and Q4 Earnings Countdown

Updated as of December 7, 2025 1. FuelCell Energy Stock Snapshot FuelCell Energy Inc. (NASDAQ: FCEL) has quietly turned into one of the more volatile—and closely watched—names in the hydrogen and fuel‑cell space as 2025 draws to a close. In other words: near‑term momentum is strong, but the longer‑term chart still screams “high volatility, high risk.” 2. December 2025 Headlines: Q4 Call Date and Fresh Financing Two corporate announcements frame the near‑term story for FCEL as of December 7, 2025: Q4 and Full‑Year 2025 Earnings on December 18 On December 4, 2025, FuelCell Energy announced it will release its fourth‑quarter
Vertex Pharmaceuticals (VRTX) Stock on December 7, 2025: Casgevy Breakthrough, Pain-Drug Setbacks and What 2026 Forecasts Are Saying

Vertex Pharmaceuticals (VRTX) Stock on December 7, 2025: Casgevy Breakthrough, Pain-Drug Setbacks and What 2026 Forecasts Are Saying

Updated: December 7, 2025 – For informational purposes only, not investment advice. 1. VRTX stock snapshot as of early December 2025 Vertex Pharmaceuticals (NASDAQ: VRTX) has had a busy—and volatile—2025. As of the close on Friday, December 5, 2025, VRTX shares finished around $455.48, giving the company a market value in the $115–117 billion range.Stock Titan+3MacroTrends+3StockInvest+3 Key numbers investors are watching right now: Technically, several short‑term models still classify VRTX as a “buy or hold candidate”: StockInvest.us, for example, highlights a strong short‑term uptrend, with the price up almost 8% over the past two weeks and an estimated 3‑month target
ConocoPhillips Stock (COP) on December 7, 2025: Latest News, Analyst Forecasts and What It Means for Investors

ConocoPhillips Stock (COP) on December 7, 2025: Latest News, Analyst Forecasts and What It Means for Investors

Ticker: NYSE: COP • Date: December 7, 2025 ConocoPhillips stock is trading just under $94 per share after a modest rebound in recent weeks. Shares have climbed roughly mid‑single digits over the past week and month, but the stock is still negative year to date, reflecting pressure from softer oil prices and company‑specific restructuring news. Yahoo Finance At the same time, the company has delivered solid third‑quarter results, raised its dividend, tightened costs, and laid out a cautious but cash‑generative outlook for 2026. Analysts broadly rate ConocoPhillips stock a “Moderate Buy” to “Buy” with double‑digit upside over the next 12
7 December 2025
Accenture (ACN) Stock Today: AI Deals, Big-Name Buyers and 2026 Price Targets – December 7, 2025

Accenture (ACN) Stock Today: AI Deals, Big-Name Buyers and 2026 Price Targets – December 7, 2025

Published: December 7, 2025 Accenture plc (NYSE: ACN) is back in the spotlight. The consulting and technology giant’s share price has been battered in 2025, but a wave of institutional buying, aggressive generative AI investments and fresh analyst forecasts are reshaping the narrative around ACN stock heading into 2026. As of the latest close on December 5, Accenture shares trade around $266.59, roughly 25% below their 52‑week high of $398.35, with a market capitalization of about $165 billion and a trailing P/E near 22. StockAnalysis+1 Key takeaways for Accenture (ACN) stock Accenture stock today: price, valuation and recent performance Accenture’s
PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

As of December 7, 2025, PDD Holdings Inc. – the Dublin‑based parent of Chinese e‑commerce platform Pinduoduo and global bargain marketplace Temu – is back in the headlines. Strong third‑quarter earnings, fresh regulatory scrutiny in the United States and Europe, and a wave of new analyst forecasts have all converged to make PDD Holdings Inc – ADR (NASDAQ: PDD) one of the most closely watched Chinese tech stocks on Wall Street. Below is a comprehensive look at the latest PDD stock price, Q3 2025 results, Temu‑related legal risks, and 2026 analyst forecasts, based on information available up to December 7,
Verizon Communications (VZ) Stock on December 7, 2025: Dividend Giant Reshapes Itself With Job Cuts, 5G Bets and a New CEO

Verizon Communications (VZ) Stock on December 7, 2025: Dividend Giant Reshapes Itself With Job Cuts, 5G Bets and a New CEO

Published: December 7, 2025 Where Verizon Stock Stands Today Verizon Communications Inc. (NYSE: VZ) closed the latest trading session at about $41–42 per share, with a 52‑week range of roughly $37.59 to $47.36. Over the past 12 months, the stock is down about 1.6%, lagging the broader U.S. equity market but outperforming its own five‑year history, where shares remain roughly 30% below their level five years ago. Simply Wall St At these prices, Verizon trades on a price‑to‑earnings multiple around 9x and offers a dividend yield close to 6.6–6.7%, based on the recently declared quarterly dividend of $0.69 per share.
7 December 2025
Lithium Americas (LAC) Stock: US Government Stake, Thacker Pass Funding and Outlook to 2030

Lithium Americas (LAC) Stock: US Government Stake, Thacker Pass Funding and Outlook to 2030

As of early December 2025, Lithium Americas Corp. (NYSE: LAC; TSX: LAC) has moved from niche lithium developer to geopolitical asset at the center of Washington’s push to onshore critical minerals. The stock has rallied hard on news that the U.S. government will own a slice of the company, even as analysts warn that meaningful cash flow may not arrive until the next decade. The Department of Energy’s Energy.gov+1 Below is a detailed look at the latest news, forecasts and analyses on Lithium Americas stock as of 7 December 2025. Where Lithium Americas Stock Stands Now On 5 December 2025,
7 December 2025
Duke Energy (DUK) Stock Today: Nuclear Bets, Rate Hikes, Dividends and 2026 Outlook — December 7, 2025

Duke Energy (DUK) Stock Today: Nuclear Bets, Rate Hikes, Dividends and 2026 Outlook — December 7, 2025

Updated: December 7, 2025 Duke Energy Corporation (NYSE: DUK) has quietly become one of the most watched U.S. utility stocks heading into 2026. Strong earnings, surging power demand from AI data centers, a massive grid‑upgrade plan and fresh nuclear ambitions are all colliding with political pushback over rate hikes and a heavy capital bill. Here’s a detailed look at the latest news, analyst forecasts and fundamental trends shaping Duke Energy stock right now. DUK stock snapshot as of early December 2025 That combination of defensive income and multi‑year share gains is a big reason DUK keeps showing up on “safe
Philip Morris International Stock on 7 December 2025: Ferrari Deal, Smoke‑Free Pivot and Conflicting 2030 Forecasts

Philip Morris International Stock on 7 December 2025: Ferrari Deal, Smoke‑Free Pivot and Conflicting 2030 Forecasts

Philip Morris International Inc. (NYSE: PM) stock is ending the first week of December 2025 in the spotlight, as investors digest a fresh earnings guidance upgrade, a deeper Ferrari partnership featuring ZYN branding in Formula 1, and a sweeping reorganization designed to accelerate the company’s “smoke‑free future” strategy. At Friday’s close, PM traded around $148 per share, giving the company a market capitalization of roughly $230 billion and placing it near the lower half of its 52‑week range of $116.12 to $186.69. The trailing P/E multiple stands near 26.8, and the forward valuation based on 2025 guidance is just under
Devon Energy (DVN) Stock Outlook December 2025: Latest News, Dividend and 2026 Forecasts

Devon Energy (DVN) Stock Outlook December 2025: Latest News, Dividend and 2026 Forecasts

Devon Energy Corporation (NYSE: DVN) heads into December 2025 back in Wall Street’s good graces. As of the close on December 5, Devon shares traded at $37.47, about 3.6% below their 52‑week high of $38.88 and well above the 52‑week low of $25.89. devonenergy.com+2investors.devonenergy.com+2 Recent performance has been strong: over the last three months the stock is up 7.8%, outpacing the Dow Jones Industrial Average’s 5.6% gain, and year‑to‑date DVN is up 14.5% versus the Dow’s 12.7%. Barchart.com That rebound has been driven by a powerful third‑quarter earnings beat, a clear 2026 spending plan, and continued shareholder payouts via dividends
Lumen Technologies (LUMN) Stock on December 7, 2025: AI Bet, Debt Reset and What the Latest News Means for Investors

Lumen Technologies (LUMN) Stock on December 7, 2025: AI Bet, Debt Reset and What the Latest News Means for Investors

As of December 7, 2025, Lumen Technologies Inc. (NYSE: LUMN) has turned into one of the most hotly debated telecom-and-AI infrastructure plays on Wall Street. After a massive 2025 rally, the stock is being pulled in opposite directions by improving cash flow, heavy leverage, and wildly different valuation models. This article pulls together the latest news, forecasts, and analysis around LUMN stock as of 7 December 2025, with a focus on what actually matters for investors following the story. 1. LUMN stock snapshot: price, performance and volatility According to recent institutional-ownership filings, Lumen shares opened around $8.27 on the most
AGNC Investment Corp (AGNC) Stock: 52‑Week High, 13%+ Yield and 2026 Outlook – December 2025 Update

AGNC Investment Corp (AGNC) Stock: 52‑Week High, 13%+ Yield and 2026 Outlook – December 2025 Update

As of the weekend of December 7, 2025, AGNC Investment Corp. (NASDAQ: AGNC) sits near a fresh 52‑week high around $10.6 per share, after touching roughly $10.65 on December 5. Over the last year the stock has delivered around 25–30% total return, yet still offers a double‑digit dividend yield near 13–14%, making it one of the most talked‑about high‑income plays heading into 2026. DividendMax+3Investing.com+3Robinhood+3 At the same time, Wall Street’s view is nuanced: consensus 12‑month price targets now sit slightly below the current share price, Zacks assigns the stock a Rank #4 (Sell), and several research houses continue to flag
7 December 2025
Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Medtronic PLC (MDT) Stock Outlook December 7, 2025: Price, Dividend, Hugo Robot FDA Win and 2026 Forecast

Updated: December 7, 2025 Key Takeaways 1. Medtronic (MDT) Stock Snapshot on December 7, 2025 As of the latest completed trading session (Dec. 5, 2025), Medtronic’s NYSE‑listed shares closed at $101.36, with modest after‑hours trading around $101.31. StockAnalysis Key stats at a glance: Trading over the last week has been choppy as markets digest macro headlines and rotations within healthcare. On Dec. 1, MDT fell about 1.9% to $103.34, underperforming the S&P 500 and Dow. A day later, it slipped another 1.3% to $102.03, leaving it around 4% below its recent 52‑week high of $106.33. MarketWatch+1 Even so, post‑earnings commentary
7 December 2025
Okta (OKTA) Stock on December 7, 2025: Earnings Beat, AI Identity Push and What Wall Street Expects Next

Okta (OKTA) Stock on December 7, 2025: Earnings Beat, AI Identity Push and What Wall Street Expects Next

Updated: December 7, 2025 Okta, Inc. (NASDAQ: OKTA), the cloud identity and access management specialist, is back in the spotlight after delivering a solid earnings beat, raising guidance and doubling down on its AI‑driven security strategy. Yet the stock is still trading well below its 52‑week high, and analysts are sharply divided on how much upside remains. Below is a detailed, news‑driven look at Okta’s latest results, AI initiatives, security track record, valuation and stock forecasts as of December 7, 2025. Key Takeaways for Okta Stock (OKTA) Okta in 2025: Where the Stock Stands Now Okta is a San‑Francisco‑based identity
DiDi Global Stock (DIDIY) on 7 December 2025: Robotaxi Breakthrough, Lawsuit Settlement and Hong Kong IPO Buzz

DiDi Global Stock (DIDIY) on 7 December 2025: Robotaxi Breakthrough, Lawsuit Settlement and Hong Kong IPO Buzz

Updated: 7 December 2025 – This article is for information only and is not investment advice. DiDi Global Inc., the Chinese ride‑hailing giant once at the center of Beijing’s tech crackdown, is back in the spotlight. In late 2025 the stock is trading in the mid‑$5 range on the U.S. over‑the‑counter market under the ticker DIDIY, with improving profits, a major U.S. lawsuit settlement close to the finish line, and a new 24/7 robotaxi trial in Guangzhou. Investing.com+2Reuters+2 At the same time, investors are watching ongoing chatter about a potential Hong Kong relisting, while Wall Street banks including Goldman Sachs

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop